SCHEDULE: FMR LLC Boosts Boston Scientific Stake to 7.5%

FMR LLC and Abigail P. Johnson have disclosed a 7.5% beneficial ownership stake in Boston Scientific Corp, holding over 110 million shares.

Summary

• FMR LLC and Abigail P. Johnson reported beneficial ownership of 110,320,937.81 shares of Boston Scientific Corp common stock as of June 30, 2025.
• This aggregate amount represents 7.5% of Boston Scientific Corp's total outstanding common stock.
• FMR LLC holds sole voting power over 99,962,678.28 shares and sole dispositive power over 110,320,937.81 shares.
• Abigail P. Johnson, as a control person of FMR LLC, is deemed to beneficially own the same aggregate amount of shares.
• The reporting persons certify that the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing the control of Boston Scientific Corp.

Sentiment

Score: 7

Explanation: The filing reveals a significant, non-activist stake by a prominent institutional investor, FMR LLC, in Boston Scientific Corp. This indicates a vote of confidence in the company's long-term prospects from a major market participant.

Positives

• The disclosure of a significant 7.5% beneficial ownership by FMR LLC, a major institutional investor, indicates a substantial long-term investment in Boston Scientific Corp.
• The stated intent that the shares are held in the ordinary course of business and not for control purposes suggests a passive, confidence-driven investment rather than an activist stance.

Future Outlook

NA

Management Comments

• The securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.

Industry Context

NA

Stakeholder Impact

• Shareholders: May experience increased confidence due to the significant institutional backing from FMR LLC.
• Management: No direct impact on Boston Scientific Corp's management or operational strategy, as the stake is explicitly stated as passive and not for control.

Key Dates

Recommendation

This Schedule 13G filing primarily serves as a disclosure of a significant beneficial ownership stake by FMR LLC and Abigail P. Johnson in Boston Scientific Corp. The 7.5% stake, held for ordinary business purposes and not for control, signals strong institutional confidence in the company. However, the filing does not contain financial performance data, strategic updates, or new operational insights that would typically drive a 'buy' or 'sell' recommendation. For existing investors, this disclosure reinforces a 'hold' position, as it suggests continued institutional belief in the company's value. For potential investors, it provides a positive signal regarding institutional interest without offering a basis for immediate action.

Keywords

Boston Scientific Corp, FMR LLC, Abigail P. Johnson, Beneficial ownership, Institutional investment, Medical devices, Healthcare, Common stock, Schedule 13G